The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against ...

For the first time, six proteomic aging clocks have been deployed as readouts in a clinical trial, revealing more about the ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced results from Late-Breaking Clinical ...

Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall ...

Denifanstat showed continued improvement and sustained efficacy across all efficacy endpoints through 52 weeks, including 57% IGA success, 72% ...

Oncolytics noted that the REO 022 results came from a small, non-randomized study and that cross-study comparisons have inherent limitations. REO 033 is intended to determine whether the efficacy ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

Glaukos Corporation announced positive topline results from the Phase 4 prospective, randomized, controlled clinical trial (GLK-101-04) evaluating iDose® TR administered in conjunction with cataract ...

Plant-derived polyphenols show biological activity relevant to endometriosis in laboratory studies, but human evidence is too ...